Literature DB >> 11566418

Drugs in postmortem adipose tissues: evidence of antemortem deposition.

J A Levisky1, D L Bowerman, W W Jenkins, D G Johnson, S B Karch.   

Abstract

INTRODUCTION: Drug concentration measured in postmortem adipose tissue may or may not reflect antemortem concentration. To examine the possibility of whether the presence of basic drugs in adipose tissue is the result of postmortem change, we examined: tissues with and without livor mortis, concentration gradients within the adipose layer, and the stability of drug concentrations during the postmortem period. CASE REPORTS: Five drug-related deaths with case histories and analytical data are presented. Adipose tissues with and without livor mortis from the thigh area of the same decedent were analyzed for cocaine. The cocaine concentration of the tissue exhibiting 4+ livor was equivalent to the concentration observed in tissue without livor. Analyses of cross sections of adipose tissues containing cocaine and methamphetamine disclosed that drug concentrations were equally distributed throughout the layer, from just beneath the dermis to directly above the muscle. When morphine and temazepam concentrations were measured in adipose tissues collected from similar sites, but at different times, from the same cadaver, they remained essentially the same over 3 days (approximately 80 h).
CONCLUSIONS: Since concentrations were the same in areas with and without livor mortis, the possibility of redistribution into adipose from blood or vascular channels is eliminated. The absence of a concentration gradient within the adipose layer rules out diffusion or permeation from muscle into the adipose layer, and the failure of morphine or temazepam concentration to change over time indicates that drugs in the adipose tissue are stable during the postmortem interval. Our findings support the notion that drugs identified in postmortem adipose tissue are there because of antemortem deposition and not because of any postmortem change or event.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566418     DOI: 10.1016/s0379-0738(01)00397-8

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  5 in total

1.  Deaths involving contraindicated and inappropriate combinations of serotonergic drugs.

Authors:  Jennifer L Pilgrim; Dimitri Gerostamoulos; Olaf H Drummer
Journal:  Int J Legal Med       Date:  2010-12-01       Impact factor: 2.686

2.  Cannabis and cardiotoxicity.

Authors:  Steven B Karch
Journal:  Forensic Sci Med Pathol       Date:  2006-03       Impact factor: 2.007

3.  Methamphetamine exposure and chronic illness in police officers: significant improvement with sauna-based detoxification therapy.

Authors:  Gerald H Ross; Marie C Sternquist
Journal:  Toxicol Ind Health       Date:  2011-11-16       Impact factor: 2.273

4.  Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs.

Authors:  Nadine Schaefer; Mattias Kettner; Matthias W Laschke; Julia Schlote; Andreas H Ewald; Michael D Menger; Hans H Maurer; Peter H Schmidt
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

5.  Is adipose tissue suitable for detection of (synthetic) cannabinoids? A comparative study analyzing antemortem and postmortem specimens following pulmonary administration of JWH-210, RCS-4, as well as ∆9-tetrahydrocannabinol to pigs.

Authors:  Nadine Schaefer; Frederike Nordmeier; Ann-Katrin Kröll; Christina Körbel; Matthias W Laschke; Michael D Menger; Hans H Maurer; Markus R Meyer; Peter H Schmidt
Journal:  Arch Toxicol       Date:  2020-07-14       Impact factor: 5.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.